Vladimir Shipkov resigns as Executive Director of AIPM

December 11, 2023, Moscow. –  The Association of International Pharmaceutical Manufacturers (AIPM) announces that Vladimir Shipkov resigns from the post of Executive Director of the Association. The decision was adopted at the General Meeting of the AIPM member-companies, held on December 6, 2023.

Vladimir Shipkov has been at the helm of the Association since 2007. Over this period, the industry, the pharmaceutical market, and AIPM which has been the leading industry association during all these years, have progressed together from laying the foundations for modern regulatory framework and ensuring the quality of medicines, as well as from the first steps in implementation of advanced healthcare assessment procedures to ensure range and price availability, to the localization of advanced pharmaceutical production facilities in Russia, technology transfer, implementation of key good practices (GxP) and transition to the supranational regulation level within the EAEU single pharmaceutical market. At each phase, the Association was a proactive solution partner in the process and contributed significantly to the development of the balanced and effective regulatory environment. The member-companies and the Association were guided in their work by the best world-acknowledge standards, aimed at expanding the availability of innovative therapies and high-quality generic drugs for the benefit of healthcare, the medical community, and patients in Russia.

The AIPM Board of Directors expresses its gratitude to Vladimir Shipkov for the fundamental work he has done over these years.

"Under the leadership of Vladimir Shipkov, the Association built the strong history, and now we are entering to the new age. We express our appreciation to him for his long-term dedicated service and wishing health and successes. The Association's operations will be carried on by the incoming AIPM leadership, who will meet new ambitious goals. The same time our commitments remain unchanged, we work to help patients and ready to bring our expertise to develop all sectors of the pharmaceutical market for the benefit of the Russian healthcare system. Among our top priorities remain protecting the interests of patients, making the most cutting-edge treatments accessible to every patient who requires them, respecting intellectual property rights, abiding by the AIPM Code's of practice, developing GxP practices, and encouraging the growth of the EAEU single pharmaceutical market. The Association's work will always be based on our ethical principles and values, along with the continuous pursuit of improvement and innovations," - stated Katerina Pogodina, Vice-Chair of the AIPM Board of Directors, Managing Director of Janssen, a pharmaceutical products division of Johnson & Johnson.

"The impact of Vladimir Shipkov on the development of the pharmaceutical sector in our country cannot be emphasized enough. His work as Executive Director of AIPM came at a challenging time of structural transformations in the industry, which required him to be highly involved in a wide range of tasks and responsibilities. It would be impossible to address the issues that the pharmaceutical industry is facing today without the establishment of transparent and predictable business environment, which came to exist in no small part thanks to Mr. Shipkov's indefatigability, energy, and unwavering commitment to upholding the interests of the professional community. As the Association enters a new development stage, our mission is to keep and expand the best traditions and practices, a high degree of professionalism, and industry expertise," stressed Vasiliy Ignatyev, member of the AIPM Board of Directors, CEO of R-Pharm.

New Association head will be elected in early 2024 in compliance with all the AIPM Statute procedures.

Reference:

The Association of International Pharmaceutical Manufacturers (AIPM) was established in 1994 and represents in the Russian Federation the leading international pharmaceutical companies - producers and developers of modern effective, safe and high-quality medicines. Today, AIPM unites 58 international companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation.

For additional information, please contact:

Elena Yankovskaya, PR & Communications Director, AIPM
+7 (495) 933 70 40, Elena.Yankovskaya@aipm.org